FDA.reportPublic FDA data

Application 077629

Type
ANDA
Sponsor
LANNETT CO INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CITALOPRAM HYDROBROMIDECITALOPRAM HYDROBROMIDESOLUTION;ORALEQ 10MG BASE/5MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0121-0848CitalopramCitalopram HydrobromidePharmaceutical Associates, Inc.ANDACurrent
0121-1696CitalopramCitalopram HydrobromidePharmaceutical Associates, Inc.ANDACurrent
17856-0540Citalopram HydrobromideCitalopram HydrobromideAtlantic Biologicals CorpsANDACurrent
54838-540Citalopram HydrobromideCitalopram HydrobromideLannett Company, Inc.ANDACurrent
54838-540Citalopram HydrobromideCitalopram HydrobromideLannett Company, Inc.ANDACurrent
54838-540Citalopram HydrobromideCitalopram HydrobromideLannett Company, Inc.ANDACurrent
54838-540Citalopram HydrobromideCitalopram HydrobromideLannett Company, Inc.ANDACurrent
54838-540Citalopram HydrobromideCitalopram HydrobromideLannett Company, Inc.ANDACurrent
62135-540CitalopramCitalopramChartwell RX, LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
44361ORIG2006-06-19